Resources

The health based guidance values are expressed as a tolerable daily intake (TDI) and can be used for assessing potential exposure to per- and poly-fluoroalkyl substances (PFAS) through food, drinking water and recreational water during site investigations.

This document contains frequently asked questions about the Perfluorinated chemicals in food report.

These spreadsheets provide 2016 quarterly childhood immunisation coverage data by Primary Health Network (PHN), for all children and Aboriginal and Torres Strait Islander children.

This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers September to December 2016.

The Administrative Record Keeping Guidelines provides useful information and tools that support good administrative record keeping within your practice.

BreastScreen Australia services and State Coordination Units (SCUs) use this form to identify which NAS measures they are responsible for as part of the accreditation process.

These guidelines for Public Health Units provide nationally consistent guidance on how to respond to Zika virus. They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA).

This interim report provided the MBS Review Taskforce with a progress update on the work of the General Practice and Primary Care Clinical Committee, as at April 2017.

This brochure provides information for consumers and carers about biosimilar medicines, including what they are, who uses them, why they’re important, and how we regulate them.

This brochure provides information for healthcare professionals about biosimilar medicines, including what they are, how they are developed, whether they differ from biological medicines, and how we monitor their safety.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for plague.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for tularaemia.

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for cryptosporidiosis.

This report presents the findings of the 2017 independent review of the Living Longer Living Better reforms. It includes 38 recommended actions to further improve the aged care system.

This flowchart shows the pathways that people take through the National Bowel Cancer Screening Program. It identifies what stages people are contacted throughout the process and who contacts them.

These guidelines for Public Health Units provide nationally consistent guidance on how to respond to typhoid and paratyphoid. They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA).

This guideline outlines what you can do to substantiate valid general ears, nose and throat surgical services were provided such as Medicare Benefits Schedule (MBS) items 41846, 41764 and 30473.

This document from the Communicable Diseases Network Australia (CDNA) is for public health units. It provides nationally consistent guidance on how to respond to the Hendra virus.

Approved aged care providers use this form to report on progress towards being in a position to provide care in respect of provisionally allocated residential care places.

Approved aged care providers use this form to notify the Secretary of the Department of Health of your intention to transfer or receive residential or flexible aged care places. You must complete all questions in the form.

Approved aged care providers use this form to apply for the first 2 extensions of the provisional allocation period for residential or flexible care places.

Approved aged care providers use this form to apply to extend the provisional allocation period beyond 6 years from the date of allocation for residential or flexible care places.

This guideline lets facilities know what to expect when scheduled for a monitoring inspection. It includes details about required pre-inspection actions, the inspection process itself, and potential post-inspection actions.

Approved aged care providers use this form to apply to vary the conditions of allocation of operational, or unused residential and flexible, places.

2015–2016 Annual Report of the Marketing in Australia of Infant Formula